MARIETTA, Ga. (AP) _ MiMedx Group Inc. (MDXG) on Tuesday reported a loss of $2.3 million in its third quarter.
The Marietta, Georgia-based company said it had a loss of 4 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.
The developer of biomaterials made from sterilized human amniotic membrane posted revenue of $63.1 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $60.3 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDXG at https://www.zacks.com/ap/MDXG
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News